| Window | Theses | Resolved | Wins | Win rate | Avg return | Median return |
|---|---|---|---|---|---|---|
| 1d | — | — | — | — | — | — |
| 3d | — | — | — | — | — | — |
| 1w | — | — | — | — | — | — |
| 1m | — | — | — | — | — | — |
| 3m | — | — | — | — | — | — |
| 6m | — | — | — | — | — | — |
| 1y | — | — | — | — | — | — |
Past performance does not predict future results. Informational only, not investment advice.
BAKER BROS. ADVISORS LP (Director at Kodiak Sciences Inc.) reported an open-market purchase of 715,592 shares of KOD at an average $88.59, roughly $63,397,609, in a Form 4 filed 2026-09-30.
BAKER BROS. ADVISORS LP (Director at Kodiak Sciences Inc.) reported an open-market purchase of 418,323 shares of KOD at an average $83.58, roughly $34,963,077, in a Form 4 filed 2026-09-30.
BAKER BROS. ADVISORS LP (Director at Kodiak Sciences Inc.) reported an open-market purchase of 807,840 shares of KOD at an average $72.57, roughly $58,625,708, in a Form 4 filed 2026-09-30.
End of results.